New drug trial aims to shrink painful joint tumors
NCT ID NCT07499362
Summary
This study is testing an oral drug called pimicotinib in Japanese patients with a rare, non-cancerous joint tumor called tenosynovial giant cell tumor (TGCT). The main goals are to see how well the drug is tolerated, how it moves through the body, and whether it can shrink the tumors and improve pain and stiffness. The study will enroll about 20 participants whose tumors cannot be safely removed by surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOSYNOVIAL GIANT CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Darmstadt, Germany
Conditions
Explore the condition pages connected to this study.